Peak Perform Innova
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Peak Perform Innova - overview
Established
2024
Location
Suzhou, Jiangsu, China
Primary Industry
Biotechnology
About
Based in Suzhou, China, and founded in 2024, Pu Nuo Zhi Yao (Suzhou) Biotechnology Co. , Ltd. , dba Peak Perform Innova, is an innovative biopharmaceutical R&D company focused on discovering and developing first‑in‑class and best‑in‑class drug candidates for high‑unmet‑need diseases. The company integrates advanced artificial intelligence technologies with biomedical research to enhance drug discovery efficiency.
In March 2026, Peak Perform Innova raised Pre-Series B funding from Huagai Capital, BioTrack Capital. The company focuses on innovative drug discovery, particularly targeting protein–protein interaction (PPI) mechanisms, and develops small‑molecule therapeutics, including novel degraders such as PROTACs and molecular glues. Its activities span medical research, engineering research, and technology commercialization. The company’s revenue is generated from out‑licensing of drug candidates, technology transfer, R&D collaboration services, and future commercialization of proprietary pharmaceutical assets.
Current Investors
Huagai Capital, Hefei State-Owned Assets Holding, Tigermed
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
peakperforminnova.com
Verticals
Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.